References

Alaminos M, Mora J, Cheung NK et al. (2003) Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res 63:4538-4546 Alvarado CS, London WB, Look AT et al. (2000) Natural history and biology of stage A neuroblastoma: a pediatric oncology group study. J Pediatr Hematol Oncol 22:197-205 Ambros PF, Ambros IM, Strehl S et al. (1995) Regression and progression in neuroblastoma: Does genetics predict tumor behavior? Eur J Cancer 3iA:5i0-5i5 Boon K, Caron HN,van Asperen R et al. (2001) N-myc enhances the expression of a large set of genes functioning in ribo-some biogenesis and protein synthesis.EMBO J 20:1383-1393 Brodeur GM, Maris JM (2002) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 4th edn. Lippincott Williams and Wilkins, Philadelphia, pp 761-797 Brodeur GM, Seeger RC, Schwab M et al. (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stages. Science 224:1121-1124 Chang NS, Mattison J, Cao H et al. (1998) Cloning and characterization of a novel transforming growth factor-beta 1 induced TIAF1 protein that inhibits tumor necrosis factor cytotoxicity. Biochem Biophys Res Commun 253:743-749 Choi LMR, Kim NW, Zuo JJ et al. (2000) Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med Pediatr Oncol

35:647-650

D'Angio GJ, Evans AE, Koop CE (1971) Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1:1046-1049

George RE, Kenyon RM, McGuckin AG et al. (1996) Investigation of co-amplification of the candidate genes ornithine decar-boxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene,DDXi,with N-myc in neuroblastoma.United Kingdom Children's Cancer Study Group. Oncogene 12:1583-1587 Grosfeld JL, Rescorla FJ, West KW et al. (1993) Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome. Semin Pediatr Surg 2:37-46 Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, Richter J, Rubin GM, Blake JA, Bult C, Dolan M, Drabkin H, Eppig JT, Hill DP, Ni L, Ringwald M, Balakrishnan R, Cherry JM, Christie KR, Costanzo MC, Dwight SS, Engel S, Fisk DG, Hirschman JE, Hong EL, Nash RS, Sethuraman A, Theesfeld CL, Botstein D, Dolinski K, Feierbach B, Berardini T, Mundodi S, Rhee SY, Apweiler R, Barrell D, Camon E, Dimmer E, Lee V, Chisholm R, Gaudet P, Kibbe W, Kishore R, Schwarz EM, Sternberg P, Gwinn M, Hannick L,Wortman J, Berriman M, Wood V, de la Cruz N, Tonellato P, Jaiswal P, Seigfried T, White R; Gene Ontology Consortium (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258-D261

Hiemstra JL, Schneider SS, Brodeur GM (1994) High-resolution mapping of the N-myc amplicon core domain in neuroblastomas. Prog Clin Biol Res 385:51-57 Hiyama E, Hiyama K, Nishiyama M et al. (2003) Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity. J Pediatr Surg 38:1730-1734 Kushner B, Cheung NK, LaQuaglia M et al. (1996) Survival from locally invasive or metastatic neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373-381 Ladanyi M, Gerald WL (2003) Expression profiling of human tumors; diagnostic and research applications. Humana Press, Totowa, New Jersey Li Y, Kang J, Horwitz MS (1998) Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 18:1601-10 Look AT, Hayes FA, Shuster JJ et al. (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 9:581-591 Ma A, Moroy T, Collum R et al. (1993) DNA binding by N- and

L-Myc proteins. Oncogene 8:1093-1098 Matthay KK, Perez C, Seeger RC et al. (1998) Successful treatment of stage III neuroblastoma based on prospective biologic staging: a children's cancer group study. J Clin Oncol 16:1256-1264

Mora J, Cheung NK, Kushner BH et al. (2000) Loss of hetero-zygosity on chromosome arm 1p correlates with clinical categories of neuroblastoma. J Mol Diagn 2:37-46 Nisen PD, Waber PG, Rich MA et al. (1988) N-myc oncogene RNA expression in neuroblastoma. J Natl Cancer Inst

80:1633-1637

Ohira M, Morhashi A, Nakamura Y et al. (2003) Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma. Cancer Lett 197:63-68

Perez CA, Matthay KK, Atkinson JB et al. (2000) Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol 18:18-26 Quackenbush J (2001) Computational analysis of microarray data. Nat Rev Genet 2:418-427 Ramaswamy S, Golub TR (2002) DNA microarrays in clinical oncology. J Clin Oncol 20:1932-1941 Rust C, Karnitz LM, Paya CV et al. (2000) The bile acid tau-rochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 275:20210-20216 Seeger RC, Brodeur GM, Sather H et al. (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116 Slavc I, Ellenbogen R, Jung WH et al. (1990) myc gene amplification and expression in primary human neuroblastomas. Cancer Res 50:1459-1463 Su WT, Alaminos M, Mora J, Cheung NK, La Quaglia MP, Gerald WL (2004) Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas. Cancer Genet Cytogenet 154:131-137 Sweeney KJ, Clark GD, Prokscha A et al. (2000) Lissencephaly associated mutations suggest a requirement for the PAFAH1B heterotrimeric complex in brain development. Mech Dev 92:263-271 Van Limpt V, Chan A, Caron H et al. (2000) SAGE analysis of neuroblastoma reveals a high expression of the human homologue of the Drosophila Delta gene. Med Pediatr Oncol

35:554-558

Van Limpt VAE, Chan AJ, van Sluis PG et al. (2003) High deltalike expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int J Cancer 105:61-69

Wulf P, Bernhardt RR, Suter U (1999) Characterization of peripheral myelin protein 22 in zebrafish (ZPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res 57:467-478

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment